News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,266 Results
Type
Article (42186)
Company Profile (456)
Press Release (666624)
Section
Business (209449)
Career Advice (2028)
Deals (36081)
Drug Delivery (97)
Drug Development (83604)
Employer Resources (170)
FDA (16402)
Job Trends (15121)
News (353680)
Policy (33134)
Tag
Academia (2636)
Alliances (51087)
Alzheimer's disease (1347)
Approvals (16351)
Artificial intelligence (189)
Bankruptcy (366)
Best Places to Work (11849)
Biotechnology (343)
Breast cancer (217)
Cancer (1624)
Cardiovascular disease (131)
Career advice (1691)
CAR-T (116)
Cell therapy (340)
Clinical research (66926)
Collaboration (634)
Compensation (317)
COVID-19 (2623)
C-suite (146)
Data (1528)
Diabetes (197)
Diagnostics (6297)
Earnings (86486)
Employer resources (147)
Events (114508)
Executive appointments (526)
FDA (17223)
Funding (562)
Gene therapy (241)
GLP-1 (671)
Government (4447)
Healthcare (19106)
Infectious disease (2720)
Inflammatory bowel disease (123)
Interviews (310)
IPO (16714)
Job creations (3734)
Job search strategy (1442)
Layoffs (461)
Legal (7998)
Lung cancer (236)
Manufacturing (228)
Medical device (13410)
Medtech (13415)
Mergers & acquisitions (19649)
Metabolic disorders (541)
Neuroscience (1747)
NextGen: Class of 2025 (6782)
Non-profit (4557)
Northern California (1934)
Obesity (309)
Opinion (208)
Patents (138)
People (58428)
Phase I (21030)
Phase II (29542)
Phase III (21820)
Pipeline (640)
Postmarket research (2603)
Preclinical (8975)
Radiopharmaceuticals (256)
Rare diseases (315)
Real estate (6061)
Regulatory (22339)
Research institute (2415)
Resumes & cover letters (352)
Southern California (1686)
Startups (3793)
United States (17600)
Vaccines (603)
Weight loss (219)
Date
Today (108)
Last 7 days (611)
Last 30 days (2509)
Last 365 days (35976)
2025 (2493)
2024 (36404)
2023 (41086)
2022 (52343)
2021 (56853)
2020 (55003)
2019 (47533)
2018 (35811)
2017 (33143)
2016 (32491)
2015 (38552)
2014 (32359)
2013 (27313)
2012 (29446)
2011 (30047)
2010 (28221)
Location
Africa (733)
Arizona (213)
Asia (39037)
Australia (6511)
California (4489)
Canada (1601)
China (379)
Colorado (201)
Connecticut (220)
Europe (85261)
Florida (629)
Georgia (152)
Illinois (447)
Indiana (252)
Maryland (715)
Massachusetts (3510)
Michigan (190)
Minnesota (325)
New Jersey (1255)
New York (1269)
North Carolina (860)
Northern California (1934)
Ohio (161)
Pennsylvania (1031)
South America (1110)
Southern California (1686)
Texas (657)
Utah (127)
Washington State (454)
709,266 Results for "argos therapeutics inc formerly merix bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO HT Install at Hong Kong Center for Neurodegenerative Diseases
December 6, 2024
·
2 min read
Press Releases
Neurocrine Biosciences Announces Amendment to Strategic Collaboration with Takeda to Develop and Commercialize Osavampator (formerly NBI-1065845/TAK-653)
January 27, 2025
·
6 min read
Press Releases
LPOXY Therapeutics, Inc. Acquires Key Assets from Xeno Biosciences Inc. to Advance C. difficile Prevention Therapy
January 6, 2025
·
3 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease
January 8, 2025
·
5 min read
Biotech Bay
Alamar Biosciences Announces Commercial Launch of the ARGO™ HT System and the NULISAseq™ Inflammation Panel 250 for Ultra-high Sensitivity Protein Analysis in Biofluids
Alamar Biosciences announced the commercial launch of the ARGO HT System for push-button, high sensitivity analysis of proteins in biofluids and the NULISAseq Inflammation Panel 250 for deep profiling of immune response.
January 4, 2024
·
3 min read
Spur Therapeutics (Formerly Freeline) Announces New Name and Brand
Spur Therapeutics, formerly Freeline Therapeutics, today announced a new name and brand to reflect its focus on developing a new generation of gene therapies and advancing the practice of genetic medicine.
June 17, 2024
·
5 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Nasdaq Grants Revelation Biosciences Inc. Continued Listing
January 6, 2025
·
5 min read
Press Releases
Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference
January 14, 2025
·
1 min read
1 of 70,927
Next
